AESLA Holds Dual Sessions on Injectables and Cryomodulation
AESLA Beauty hosted two academic sessions on October 8, 2026 at IMAX Paragon Cineplex in Bangkok, drawing over 500 doctors. The morning session focused on combining REVANESSE® and PLINEST® for structural and skin quality improvements, while the afternoon introduced Cryomodulation™ technology from Silicon Valley. Notable speakers included Prof. Henry H.L. Chan, one of Cryomodulation’s scientific founders.
AESLA Beauty opened two academic programs in a single day, advancing knowledge from Aesthetic Injectables to Cryomodulation at IMAX Paragon Cineplex. AESLA Beauty held two cosmetic medicine sessions on October 8, 2026 at IMAX, Paragon Cineplex, 5th floor, with over 500 doctors registered.
The morning session was 'Lift & Glow — When Structure Meets Radiance: PROGRAM · REVANESSE® × PLINEST®', conveying the Combination Approach concept that links structural care and skin quality through appropriate planning of REVANESSE® (hyaluronic acid) and PLINEST® (polynucleotide) for each individual.
The event featured Dr. Chonthawat Suwanpiyasiri, Dr. Thannawut Yahthakari, Dr. Punyanun Boonchaya, and Dr. Panichanat Puspipichanan sharing knowledge from basic science, anatomy, safety to clinical application of combination treatment in real cases.
The afternoon session was 'GLACIAL® CRYOMODULATION: The New Frontier in Aesthetic Medicine', presenting the science of controlled cooling from basics to application in aesthetic medicine.
Cryomodulation technology was developed under R2 Technologies from Silicon Valley, USA, with scientific founders R. Rox Anderson, M.D., Dieter Manstein, M.D., Ph.D., and Henry H.L. Chan, M.D., Ph.D.
A highlight was the presence of Prof. Henry H.L. Chan, M.D., Ph.D., one of the scientific founders, who personally shared knowledge, alongside Prof. Worapong Manaskeerti, Dr. Witthai Hongsarach, and Assoc. Prof. Punyapas Sirithanadeekul.
Organizing the two academic sessions reflects AESLA’s approach of connecting science, clinical application, and treatment planning to open new perspectives for personalized, comprehensive treatment planning.